microdose glp-1 menopause Ashley Koff on GLP-1s and Weight in Perimenopause: When They Help, When They Harm, and the Red Flags You're Missing Microdosing GLP‑1 in Menopause &

Until such approvals are granted, the medication remains an investigational agent

Common adverse effectsnausea, vomiting, diarrheatypically diminish with gradual dose titration

Am J Hypertens

If you want a broader overview of how these medications work, our guide on what GLP-1 is and how it works is a helpful starting point

Patients with uncontrolled tachyarrhythmias, recent acute coronary syndrome, or unstable heart conditions should exercise caution and require thorough cardiovascular assessment before starting treatment

Reading how that recurring layer is assembled is the first step to judging whether it actually fits your needs over time